JIANG, HAIYAN,DIAO, LEI,LI, SHUANGLIAN,COBB, PAULA
申请号：
EP13847770
公开号：
EP2908847A4
申请日:
2013.10.18
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The present invention provides methods of administering a clotting factor by a fixed dosing regimen； methods of reducing, ameliorating, or preventing one or more symptoms of a bleeding disease or disorder； and a kit comprising a dotting factor useful for a fixed dosing regimen. While plasma-derived and recombinant clotting factor products allow hemophilia patients to live longer and healthier, hemophilia still remains one of the most costly and complex conditions to manage.
